Asset Manager

Updated:

Excalibur Fund Managers

Excalibur Fund Managers is a London-based venture capital firm focused on human medicines. They invest in science and entrepreneurship, providing medical and...

Excalibur Fund Managers

Excalibur Fund Managers is a London-based venture capital firm focused on human medicines. They invest in science and entrepreneurship, providing medical and healthcare facilities. Excalibur Fund Managers has made 46 investments, including a Series F investment in TME Pharma on May 19, 2010.

General information

Firm type

Asset Manager

Year founded

2008

AUM

$100M - $500M (Altss estimate)

Location

Region

Middle East

Country

Portugal

City

Lisbon

Corporate office

Lisbon, Portugal

Additional offices

Mountain View, CA, United States · Jerusalem, Israel · London, United Kingdom · Tel Aviv, Israel

Principals

Carlos Estefan

Managing Partner

Gilad Shany

Managing Partner

Sector focus

CybersecurityEnterprise SoftwareAI/MLDigital Health

Frequently asked questions

Who makes investment decisions at Excalibur Fund Managers?

Managing Partners Gilad Shany and Carlos Estefan lead investment decisions. Shany brings operational and intelligence-community experience from Israel's defense technology sector, while Estefan oversees fund structuring and European institutional relationships. The firm's investment committee likely draws on the cross-border expertise of its distributed team, given the multi-jurisdictional nature of its deal flow.

Does Excalibur invest exclusively in Israeli companies?

No. While the firm's venture thesis is anchored in Israeli dual-use technology talent, Excalibur sources and supports companies across Israel, Portugal, the broader EU, and the United States. Its Portuguese fund domicile specifically enables European startups with defense-aligned IP to access the firm's capital and transatlantic scaling network.

What is Excalibur's relationship to the Portuguese tech ecosystem?

Excalibur uses Lisbon as its European regulatory and operational headquarters, which doubles as a soft-landing platform for Israeli startups entering the EU market. The firm has publicly framed its Portuguese presence as a gateway for portfolio companies to engage with EU innovation programs and defense funding mechanisms, particularly under Horizon Europe (per CTECH, 2022).

How does Excalibur source its deal flow?

The firm leverages Managing Partner Gilad Shany's network within Israel's cybersecurity incubators and intelligence-adjacent venture circles, combined with Carlos Estefan's European institutional relationships. This dual channel gives Excalibur access to startups that emerge from government-affiliated technology programs in Israel, alongside deep-tech clusters in Portugal and the broader EU.

What types of limited partners back Excalibur's funds?

Public record indicates European family offices, institutional allocators, and public-sector innovation funds form Excalibur's LP base. The European fund structure in Portugal is specifically designed to accommodate LPs that prefer regulated EU vehicles over direct exposure to standalone Israeli venture funds, addressing a known compliance barrier.

Does Excalibur focus on early-stage or growth-stage investments?

Excalibur targets early-stage companies, typically seed and Series A rounds. The dual-use thesis requires engagement before companies have fully defined their commercial-versus-government product paths, positioning the firm as a formative-stage investor rather than a growth-capital provider.

Are Excalibur's portfolio companies primarily defense contractors?

Not solely. While the firm seeks dual-use technologies with defense or critical-infrastructure applications, it explicitly supports the commercial scaling of that IP into enterprise and allied-government markets. The Portuguese office structure is built to help these companies access civilian EU technology programs alongside defense procurement channels.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Lisbon Asset Manager profiles